Giulia R. Galli

Pavia, Italy

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 92 publications

From fragmentation to focus: building collaborative networks for rare cancer research - the Italian TYME network as a model for care and innovation?

From fragmentation to focus: building collaborative networks for rare cancer research - the Italian TYME network as a model for care and innovation?

Journal: Expert review of anticancer therapy
Published: August 24, 2026

Hyperprogression Upon Cemiplimab Alone or With Short Course Chemotherapy in PD-L1 ≥ 50% Non-small Cell Lung Cancer: A Biomarker Guided Multicenter International Phase 2 Trial-HYPERBOLIC Study.

Hyperprogression Upon Cemiplimab Alone or With Short Course Chemotherapy in PD-L1 ≥ 50% Non-small Cell Lung Cancer: A Biomarker Guided Multicenter International Phase 2 Trial-HYPERBOLIC Study.

Journal: Clinical lung cancer
Published: January 11, 2026

Thyroid toxicity in lung cancer patients treated with immune-checkpoint inhibitors: a single-center retrospective analysis.

Thyroid toxicity in lung cancer patients treated with immune-checkpoint inhibitors: a single-center retrospective analysis.

Journal: Frontiers in immunology
Published: November 30, 2025

Sequential chemo-durvalumab, reduced-dose RT, and consolidation durvalumab for unresectable stage III NSCLC unfit for PACIFIC regimen (DEDALUS trial).

Sequential chemo-durvalumab, reduced-dose RT, and consolidation durvalumab for unresectable stage III NSCLC unfit for PACIFIC regimen (DEDALUS trial).

Journal: JNCI cancer spectrum
Published: November 18, 2025

Treatment response after induction therapy in advanced thymic tumors: results from the Italian nationwide TYME database.

Treatment response after induction therapy in advanced thymic tumors: results from the Italian nationwide TYME database.

Journal: Lung cancer (Amsterdam, Netherlands)
Published: September 27, 2025

A non-small cell lung cancer fragile elderly patient treated with immunotherapy and non-ablative radiation therapy: a case report of a winning combination.

A non-small cell lung cancer fragile elderly patient treated with immunotherapy and non-ablative radiation therapy: a case report of a winning combination.

Journal: Frontiers in oncology
Published: June 06, 2025

APOLLO11: a bio-data-driven model for clinical and translational research in lung cancer.

APOLLO11: a bio-data-driven model for clinical and translational research in lung cancer.

Journal: NPJ precision oncology
Published: April 03, 2025

Malignant Pleural Mesothelioma: From Pathophysiology to Innovative Actionable Targets.

Malignant Pleural Mesothelioma: From Pathophysiology to Innovative Actionable Targets.

Journal: Cancers
Published: February 28, 2025

Light-Activated Pharmacological Tools for Exploring the Cholinergic System.

Light-Activated Pharmacological Tools for Exploring the Cholinergic System.

Journal: Medicinal research reviews
Published: January 02, 2025

Chronic Pain Modulates Empathic Responses in People with Spinal Cord Injury.

Chronic Pain Modulates Empathic Responses in People with Spinal Cord Injury.

Journal: Journal of clinical medicine
Published: October 31, 2024

Phase I Clinical Trial on Pleural Mesothelioma Using Neoadjuvant Local Administration of Paclitaxel-Loaded Mesenchymal Stromal Cells (PACLIMES Trial): Study Rationale and Design.

Phase I Clinical Trial on Pleural Mesothelioma Using Neoadjuvant Local Administration of Paclitaxel-Loaded Mesenchymal Stromal Cells (PACLIMES Trial): Study Rationale and Design.

Journal: Cancers
Published: August 14, 2024

CT and MRI radiomic features of lung cancer (NSCLC): comparison and software consistency.

CT and MRI radiomic features of lung cancer (NSCLC): comparison and software consistency.

Journal: European radiology experimental
Published: January 31, 2024
Showing 1-12 of 92

Last Updated: 09/26/2026